The Oklahoman

Apo B testing can help assess cardio health Adam’s Journal

- Body Work James is executive vice president and chief medical officer of the Oklahoma Medical Research Foundation. Cohen, a marathoner, is OMRF’s senior vice president and general counsel. Send your health questions to contact@omrf.org.

I’ve recently read and heard about testing for something called Apo B. In particular, I’ve been told that it can be a more accurate predictor for heart attack risk than traditiona­l cholestero­l testing.

Is this true?

Dr. James Prescribes

Apolipopro­tein B, or Apo B, is a protein that carries cholestero­l in our blood. Cholestero­l is a fatty substance produced by the liver, and some foods — like fried food and processed meat — can increase the amount of cholestero­l circulatin­g in our blood. There’s strong evidence linking higher levels of blood cholestero­l, especially the type known as low-density lipoprotei­n (LDL) cholestero­l, with risk for cardiovasc­ular disease. Specifically, it can cause plaque build-up in our arteries and hardening of blood vessels, which can lead to heart attacks and strokes.

At the Oklahoma Medical Research Foundation, the late Dr. Petar Alaupovic helped pioneer the study of apolipopro­teins. Apo B, the best-known of these compounds, is the main structural component of LDL cholestero­l and other forms of cholestero­l most associated with cardiovasc­ular risk. As a result, measuring Apo B can serve as a proxy for measuring all of the so-called “bad” forms of cholestero­l.

Testing Apo B levels can help predict heart attack risk, and physicians typically order it when they’re seeking an additional way to measure a person’s cardiovasc­ular disease risk. So, it’s often used as a supplement to the traditiona­l lipid panel, which gauges LDL cholestero­l as well as a number of other forms of cholestero­l and fatty compounds called triglyceri­des.

In a 2021 study in the journal The Lancet, researcher­s found that elevated levels of Apo B were associated with shorter lifespans, and the data suggested it was a stronger predictor than LDL levels. Apo B testing has also been found to be more helpful than a lipid panel at measuring cardiac risk for people with diabetes or metabolic syndrome. But whether it’s a more accurate predictor of cardiovasc­ular disease in the general population remains an open question.

Without doubt, Apo B testing is a useful tool for assessing cardiovasc­ular health. I would not recommend it as a substitute for a full lipid panel, but it can provide valuable additional informatio­n. Heart disease remains the leading cause of death in the U.S., and all of us should make it a priority to get screened regularly to know our risk.

 ?? ?? Testing Apo B levels can help predict heart attack risk, and physicians typically order it when they’re seeking an additional way to measure a person’s cardiovasc­ular disease risk. BRIANAJACK­SON/GETTY IMAGES
Testing Apo B levels can help predict heart attack risk, and physicians typically order it when they’re seeking an additional way to measure a person’s cardiovasc­ular disease risk. BRIANAJACK­SON/GETTY IMAGES
 ?? Adam Cohen and Dr. Judith James Guest columnists ??
Adam Cohen and Dr. Judith James Guest columnists
 ?? ??

Newspapers in English

Newspapers from United States